HIGHLIGHTS
- who: . and colleagues from the Hebrew University of Jerusalem, Israel Jiangsu University, China have published the Article: Therapeutic effect and rebound evaluation of dapagli ozin on glycated hemoglobin (HbA1c) in type 1 diabetes mellitus patients, in the Journal: (JOURNAL)
- what: In the present study, information on source, group, dapagliflozin dosage, duration of treatment, HbA1c, number of people, age, duration of T1DM, and total baseline insulin dose was collected from these randomized controlled trials. The goodness-of-fit plots of the model (observations vs. predictions and observations/predictions vs. time), individual plots, and conditional weighted residual . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.